Pregabalin (Lyrica) Action In Neuropathic Pain Syndrome (PAINS): A Post Marketing Surveillance Study On Efficacy, Safety And Tolerability Of Pregabalin.
Phase of Trial: Phase IV
Latest Information Update: 13 Jan 2010
At a glance
- Drugs Pregabalin (Primary)
- Indications Neuropathic pain
- Focus Therapeutic Use
- Acronyms PAINS
- Sponsors Pfizer
- 19 Nov 2009 Actual patient number (2278) added as reported by ClinicalTrials.gov.
- 18 Nov 2009 Actual end date changed from Jul 2008 to Aug 2008 as reported by ClinicalTrials.gov.
- 07 May 2009 New trial record